BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15627518)

  • 1. Potential role for nonesterified fatty acids in beta-adrenoceptor-induced increases in brain tryptophan.
    Lenard NR; Dunn AJ
    Neurochem Int; 2005 Jan; 46(2):179-87. PubMed ID: 15627518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of beta2- and beta3-adrenergic receptors increases brain tryptophan.
    Lenard NR; Gettys TW; Dunn AJ
    J Pharmacol Exp Ther; 2003 May; 305(2):653-9. PubMed ID: 12606631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased insulin is not required for beta2-adrenoceptor-induced increases in mouse brain tryptophan.
    Lenard NR; Dunn AJ
    Eur J Pharmacol; 2004 Aug; 497(1):105-10. PubMed ID: 15321741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in beta 3-adrenergic receptor cardiovascular regulation in conscious primates, rats and dogs.
    Shen YT; Cervoni P; Claus T; Vatner SF
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1435-43. PubMed ID: 8819531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the beta 2-adrenoceptor agonist clenbuterol on tyrosine and tryptophan in plasma and brain of the rat.
    Edwards DJ; Sorisio DA; Knopf S
    Biochem Pharmacol; 1989 Sep; 38(18):2957-65. PubMed ID: 2551300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desensitization effect of in vivo treatment with metaproterenol on beta1, beta2 and beta3-adrenergic responsiveness in rat adipocytes.
    Portillo MP; Del Barrio AS; Garcia-Calonge MA; Martinez JA
    Life Sci; 1996; 58(5):405-14. PubMed ID: 8594305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
    Hutchinson DS; Summers RJ; Gibbs ME
    J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-3 adrenergic receptor agonists cause an increase in gastrointestinal transit time in wild-type mice, but not in mice lacking the beta-3 adrenergic receptor.
    Fletcher DS; Candelore MR; Grujic D; Lowell BB; Luell S; Susulic VS; Macintyre DE
    J Pharmacol Exp Ther; 1998 Nov; 287(2):720-4. PubMed ID: 9808702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of beta-adrenergic agonists on lipolysis and lipogenesis by porcine adipose tissue in vitro.
    Peterla TA; Scanes CG
    J Anim Sci; 1990 Apr; 68(4):1024-9. PubMed ID: 1970556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niacin stimulates adiponectin secretion through the GPR109A receptor.
    Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of dexamethasone in sensitizing the beta-2-adrenergic receptor system in vivo in calves during concomitant treatment with clenbuterol.
    Abraham G; Gottschalk J; Ungemach FR
    Pharmacology; 2004 Nov; 72(3):196-204. PubMed ID: 15452369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevation of serum free tryptophan, but not brain tryptophan, by serum nonesterified fatty acids.
    Madras BK; Cohen EL; Munro HN; Wurtman RJ
    Adv Biochem Psychopharmacol; 1974; 11(0):143-51. PubMed ID: 4845697
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of beta 2-adrenoceptor agonists on serotonin biochemistry and function.
    Green AR; Cowen PJ; Nimgaonkar VL; Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1984; 39():285-8. PubMed ID: 6205560
    [No Abstract]   [Full Text] [Related]  

  • 14. High isoproterenol doses are required to activate beta3-adrenoceptor-mediated functions in dogs.
    Pelat M; Verwaerde P; Galitzky J; Lafontan M; Berlan M; Senard JM; Montastruc JL
    J Pharmacol Exp Ther; 2003 Jan; 304(1):246-53. PubMed ID: 12490598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta3-adrenergic eNOS stimulation in left ventricular murine myocardium.
    Brixius K; Bloch W; Ziskoven C; Bölck B; Napp A; Pott C; Steinritz D; Jiminez M; Addicks K; Giacobino JP; Schwinger RH
    Can J Physiol Pharmacol; 2006 Oct; 84(10):1051-60. PubMed ID: 17328145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective regulation of beta-2 adrenergic receptors by the chronic administration of the lipophilic beta adrenergic receptor agonist clenbuterol: an autoradiographic study.
    Vos P; Davenport PA; Artymyshyn RP; Frazer A; Wolfe BB
    J Pharmacol Exp Ther; 1987 Aug; 242(2):707-12. PubMed ID: 2886650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs influencing plasma and brain tryptophan.
    Curzon G; Knott PJ
    Br J Pharmacol; 1973 Jun; 48(2):352P-353P. PubMed ID: 4354804
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined effects of oleoyl-estrone and a beta3-adrenergic agonist (CL316,243) on lipid stores of diet-induced overweight male Wistar rats.
    Ferrer-Lorente R; Cabot C; Fernández-López JA; Alemany M
    Life Sci; 2005 Sep; 77(16):2051-8. PubMed ID: 15935402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta2-adrenoceptor-mediated prejunctional facilitation and postjunctional inhibition of sympathetic neuroeffector transmission in the guinea pig vas deferens.
    Todorov LD; Clerkin R; Mihaylova-Todorova ST; Khoyi MA; Westfall DP
    J Pharmacol Exp Ther; 2001 Aug; 298(2):623-33. PubMed ID: 11454924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an update.
    Weyer C; Gautier JF; Danforth E
    Diabetes Metab; 1999 Mar; 25(1):11-21. PubMed ID: 10335419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.